At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Apr 16, 2026 at 09:32 ET
Emergent BioSolutions Inc. (EBS) filed its definitive proxy statement (DEFA14A) for its 2026 Annual Meeting of Stockholders, scheduled for April 29, 2026. The filing outlines proposals for shareholder voting, including director elections and executive compensation, as part of routine corporate governance. No material changes or activist challenges are indicated.
- Filing is a routine proxy statement (DEFA14A) for the 2026 Annual Meeting of Stockholders
- Meeting date set for April 29, 2026
- No indication of dissident or activist involvement
- Proposals include standard items: election of directors, executive compensation, and shareholder proposals
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access